EUVIMEDEUVIMED entdecken
Crossref

Anethole trithione mitigates LPS/D-Gal-induced acute liver injury by suppressing ROS production and NF-κB activity

Zhen He, Xiangyun Tan, Ming Yuan, Liang Chen, Yan Meng, Qi Wang, Junjie Hu, Zhenpeng Qiu, Yuan Yang

International Immunopharmacology · 2025

DOI: 10.1016/j.intimp.2025.114371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2025. Verfasst von Zhen He und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China. Hauptthemen laut MEDLINE: NF-kappa B, Chemical and Drug Induced Liver Injury, Thiones, Anisoles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute liver injury (ALI) is a prevalent form of hepatic disease associated with significant morbidity and mortality due to medical treatments, exposure to toxins or viral infections. Anethole trithione (ATT) is a heterocyclic sulfur compound recognized for its chemoprotective properties against cancer and drug-induced toxicity. This study aimed to evaluate the effectiveness of ATT in the treatment of ALI. The therapeutic effects of ATT on hepatic injury were evaluated in vivo by inducing ALI in mice through the administration of lipopolysaccharide (LPS) and D-galactosamine (D-Gal). Additionally, HepG2 and Huh7 cells exposed to LPS were utilized to investigate the underlying mechanisms in vitro. The results indicated that ATT significantly reduced the production of reactive oxygen species (ROS), mitigated oxidative stress-related biochemical markers, and inhibited hepatocyte apoptosis in vivo, resulting in marked improvement in ALI in the murine model. Mechanistic studies conducted both in vivo and in vitro demonstrated that ATT alleviates LPS/D-Gal-induced ALI by inhibiting ROS production and the activity of nuclear factor-kappa B (NF-κB). Collectively, these findings underscore the potential therapeutic benefits of ATT in the management of ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BChemical and Drug Induced Liver InjuryThionesAnisolesAnimalsReactive Oxygen SpeciesLipopolysaccharidesHumansGalactosamineMiceMaleAllylbenzene DerivativesApoptosisOxidative StressLiverDisease Models, AnimalHep G2 CellsHepatocytesMice, Inbred C57BL

Stichwörter der Autor:innen

Acute liver injuryApoptosisLPS/D-GalNF-κBROS

Substanzen

Reactive Oxygen SpeciesLipopolysaccharidesNF-kappa BGalactosamineAllylbenzene DerivativesThionesanetholeAnisoles

Autor:innen und Institutionen

  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China.
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China. Electronic address: 2737@hbucm.edu.cn.
  • School of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China; Center of Traditional Chinese Medicine Modernization for Liver Diseases, Hubei University of Chinese Medicine, Wuhan 430065, China; Hubei Ke…
  • Institute of Maternal and Child Health, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430016, China. Electronic ad…

Zitieren

APA

He, Z., Tan, X., Yuan, M., Chen, L., Meng, Y., Wang, Q., Hu, J., Qiu, Z., & Yang, Y. (2025). Anethole trithione mitigates LPS/D-Gal-induced acute liver injury by suppressing ROS production and NF-κB activity. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2025.114371

Vancouver

He Z, Tan X, Yuan M, Chen L, Meng Y, Wang Q, et al. Anethole trithione mitigates LPS/D-Gal-induced acute liver injury by suppressing ROS production and NF-κB activity. International Immunopharmacology. 2025. doi:10.1016/j.intimp.2025.114371

BibTeX
@article{He2025,
  author = {He, Zhen and Tan, Xiangyun and Yuan, Ming and Chen, Liang and Meng, Yan and Wang, Qi and Hu, Junjie and Qiu, Zhenpeng and Yang, Yuan},
  title = {Anethole trithione mitigates LPS/D-Gal-induced acute liver injury by suppressing ROS production and NF-κB activity},
  journal = {International Immunopharmacology},
  year = {2025},
  doi = {10.1016/j.intimp.2025.114371}
}
Kostenlos starten →